GlassScriptPhysician profile
Reynold S Agard
NPI 1902811730
$8,211.98
in general payments reported to CMS, 2019-2025
46 companies · $1,170 in 2025
The $1,170 reported for 2025 was more than what 87% of Internal Medicine providers received nationally (typical 2025 total: $156).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $1,917 · 2020: $535 · 2021: $784 · 2022: $1,346 · 2023: $1,223 · 2024: $1,237 · 2025: $1,170.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $3,630.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $3,630.08 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Glaxosmithkline, LLC. | $1,035.67 | 2019-2025 | Trelegy Ellipta, Arexvy, Shingrix |
| Astrazeneca Pharmaceuticals LP | $953.71 | 2019-2025 | Breztri, Airsupra, Farxiga |
| Abbvie INC. | $741.67 | 2021-2024 | Vraylar, Ubrelvy |
| Lilly USA, LLC | $617.14 | 2019-2025 | Mounjaro, Zepbound, Jardiance |
| Pfizer INC. | $542.30 | 2019-2025 | |
| Janssen Pharmaceuticals, INC | $531.74 | 2019-2020 | |
| Novo Nordisk INC | $493.53 | 2019-2025 | Rybelsus, Ozempic |
| Boehringer Ingelheim Pharmaceuticals, INC. | $437.57 | 2019-2025 | Jardiance |
| Amgen INC. | $344.40 | 2019-2025 | Evenity, Prolia, Otezla |
| Bayer Healthcare Pharmaceuticals INC. | $302.60 | 2021-2024 | |
| Novartis Pharmaceuticals Corporation | $279.21 | 2019-2025 | |
| Abbott Laboratories | $207.00 | 2022-2025 | Freestyle Libre 3 |
| Otsuka America Pharmaceutical, INC. | $176.14 | 2021-2025 | Rexulti |
| Astellas Pharma US INC | $140.62 | 2019-2025 | Veozah |
| Biohaven Pharmaceutical Holding Company LTD. | $132.06 | 2022 |
Show all 46 companies
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Reynold Agard listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.